Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Tarceva

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Tarceva was produced by Roche and Astellas.

Roche drug fails in lung cancer trial

Roche drug fails in lung cancer trial The METLung study looked at the effect of adding onartuzumab to Tarceva (erlotinib) as a second- or third-line therapy for patients with non-small cell lung cancer (NSCLC), but use ... of the drugs in combination was unable to demonstrate any "clinically

NICE reviews lung cancer drug guidance

NICE reviews lung cancer drug guidance Consults on availability of Roche's Tarceva and AZ's Iressa on NHS. ... The National Institute for Health and Care Excellence (NICE) has said it is reviewing the current guidance for two lung cancer drugs: Roche's Tarceva and AstraZeneca's Iressa.

Blow to Pfizer as dacomitinib fails in lung cancer trials

Blow to Pfizer as dacomitinib fails in lung cancer trials EGFR inhibitors such as Roche/Astellas' Tarceva (erlotinib) and AstraZeneca's Iressa (gefitinib) have emerged as an important new therapy class for NSCLC in recent years, with the two products achieving ... The ARCHER 1009 trial failed to meet its

Boehringer to help promote genetic biomarker testing

Boehringer to help promote genetic biomarker testing Other drugs developed to target EGFR patients include Roche's Tarceva (erlotinib).

Boehringer files nintedanib for lung cancer in Europe

Boehringer files nintedanib for lung cancer in Europe Having two drugs may help Boehringer wrestle market share from current NSCLC treatments such as Roche's Avastin (bevacizumab) and Tarceva (erlotinib; co-marketed with Astellas) and AstraZeneca's Iressa (gefitinib).

[ Previous 5 results ] 8 9 10 11 12 13 14 15 16 17 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics